HCT116 |
Cytostatic activity assay |
10 uM |
24 hrs |
Cytostatic activity against human HCT116 cells assessed as reduction in colony forming at 10 uM after 24 hrs by crystal violet staining based assay |
29727569 |
HCT116 |
Cytostatic activity assay |
10 uM |
7 days |
Cytostatic activity against human HCT116 cells assessed as reduction in colony forming at 10 uM after 7 days by crystal violet staining based assay |
29727569 |
U937 |
Antiproliferative assay |
0.01 to 10 uM |
3 days |
Antiproliferative activity against CFSE-labeled human U937 cells at 0.01 to 10 uM after 3 days by propidium iodide staining-based flow cytometry |
29939742 |
THP1 |
Antiproliferative assay |
0.01 to 10 uM |
3 days |
Antiproliferative activity against CFSE-labeled human THP1 cells at 0.01 to 10 uM after 3 days by propidium iodide staining-based flow cytometry |
29939742 |
U937 |
Function assay |
0.1 to 10 uM |
up to 4 days |
Induction of myeloid differentiation in human U937 cells assessed as increase in CD11b expression level at 0.1 to 10 uM up to 4 days by propidium iodide staining-based flow cytometry |
29939742 |
THP1 |
Function assay |
0.1 to 10 uM |
up to 5 days |
Induction of myeloid differentiation in human THP1 cells assessed as increase in CD11b expression level at 0.1 to 10 uM up to 5 days by propidium iodide staining-based flow cytometry |
29939742 |
THP1 |
Function assay |
0.1 to 10 uM |
up to 5 days |
Induction of myeloid differentiation in human THP1 cells assessed as increase in CD14 expression level at 0.1 to 10 uM up to 5 days by propidium iodide staining-based flow cytometry |
29939742 |
Jurkat |
Antiproliferative assay |
|
72 hrs |
Inhibition of cell proliferation of human Jurkat cells incubated for 72 hrs by Celltiter-Glo assay, IC50=0.2μM |
26079043 |
MDCK |
Antiviral assay |
|
48 hrs |
Antiviral activity against VSV infected in MDCK cells assessed as inhibition of VSV replication after 48 hrs by plaque assay, EC50=0.3μM |
23930152 |
MDCK |
Antiviral assay |
|
48 hrs |
Antiviral activity against influenza A virus A/WSN/33 (H0N1) infected in MDCK cells after 48 hrs by plaque assay, EC50=0.46μM |
23930152 |
HL60 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay, IC50=0.544μM |
29727569 |
HCT116 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human HCT116 cells over-expressing DHODH after 72 hrs by MTT assay, IC50=0.679μM |
29727569 |
Jurkat T |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human Jurkat T cells assessed as DNA content after 72 hrs by Hoechst 33258 dye-based fluorescence assay, IC50=0.91μM |
29939742 |
Jurkat T |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human Jurkat T cells assessed as DNA content after 72 hrs by Hoechst 33258 dye based fluorometric method, IC50=0.93μM |
28235702 |
MIAPaCa2 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human MIAPaCa2 cells after 72 hrs by MTT assay, IC50=1.69μM |
29727569 |
Jurkat T |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human Jurkat T cells assessed as compound concentration required to induce up to 30% cell death after 72 hrs by Hoechst 33258 dye based fluorometric method, Activity=45μM |
28235702 |
Jurkat T |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human Jurkat T cells assessed as compound concentration required to induce =>30% cell death after 72 hrs by CellTox green assay, Activity=48.2μM |
29939742 |
HCT116 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human HCT116 cells over-expressing DHODH at 2 times antiproliferative IC50 after 72 hrs in absence of uridine by MTT assay |
29727569 |
insect cells |
Function assay |
|
|
Inhibition of human recombinant DHODH expressed in baculovirus infected insect cells using dihydroorotate as substrate in presence of quinone by dichlorophenol-indophenol dye based assay, IC50=0.01μM |
27994748 |
A549 |
Antiviral assay |
|
|
Antiviral activity against Yellow fever virus infected in human A549 cells assessed as reduction in virus replication, EC50=0.078μM |
31557612 |
A549 |
Antiviral assay |
|
|
Antiviral activity against West Nile virus infected in human A549 cells assessed as reduction in virus replication, EC50=0.078μM |
31557612 |
A549 |
Antiviral assay |
|
|
Antiviral activity against Dengue virus infected in human A549 cells assessed as reduction in virus replication, EC50=0.078μM |
31557612 |
A549 |
Antiviral assay |
|
|
Antiviral activity against Western equine encephalomyelitis virus infected in human A549 cells assessed as reduction in virus replication, EC50=0.078μM |
31557612 |
A549 |
Antiviral assay |
|
|
Antiviral activity against Vesicular stomatitis virus infected in human A549 cells assessed as reduction in virus replication, EC50=0.078μM |
31557612 |